Anna Amela Valsecchi

MD, PhD @unito 🌺 Ospedale Molinette, Torino

[Anna Amela Valsecchi @AAValsecchi]

Look at our last @meeturoIT review 📌

[Meet-URO @meeturoIT]

Can #biomarkers guide first-line treatment in #mRCC?
Our systematic review explores molecular & circulating biomarkers across phase III trials. Promising signals are emerging, but no validated biomarker yet guides treatment selection.

#PrecisionOncology

https://t.co/Tb8BoNYh2N

[Anna Amela Valsecchi @AAValsecchi]

Meet-URO ❤️‍🔥 Gruppo young

[Anna Amela Valsecchi @AAValsecchi]

Vi aspettiamo domani 💪🏽 @cittasalute_to

[Tumori Journal @TumoriJ]

💥Recognising #FinantialToxicity as a prognostic factor and integrating targeted support services, educational strategies and systemic reforms could substantially improve patient outcomes, #QoL, treatment adherence and equity in #CancerCare delivery.

Learn more at the link
🔓https://t.co/wSGRIMdt8c

@MassimoDiMaio75 @fperrone62 @AAValsecchi

[Anna Amela Valsecchi @AAValsecchi]

👇🏻

[Massimo Di Maio @MassimoDiMaio75]

Have a look at this publication in @TumoriJ by @AAValsecchi Pamela Festa Maria Laura Malgarini:
Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancer

https://t.co/fYsLMw8LiT

(1/5)

[Anna Amela Valsecchi @AAValsecchi]

🩷 #Breast cancer campus, Firenze

[Meet-URO @meeturoIT]

Meeturo Young at #Aiom2025

@AAValsecchi @Simorota6 @dici_mattia

[Massimo Di Maio @MassimoDiMaio75]

Even within the same country (Italy), use of off-label cancer drugs is subject to significant inter-hospital variability.
This leads to potential disparities in patients' access to care.
Have a look at the project by @AIOMtweet, just published on @TumoriJ:
https://t.co/Dy3AXUa5Xx

[Meet-URO @meeturoIT]

Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review.

Doi: https://t.co/sGT6l0TC9S

@AAValsecchi #meeturo #clinicalgenitourinarycancer

[Anna Amela Valsecchi @AAValsecchi]

Bellissimo congresso!
Ringrazio #AIOM per l’invito a parlare di “Oncologia, Industria e #Comunicazione: quando la scienza arriva nei titoli stampa” 📌

[Anna Amela Valsecchi @AAValsecchi]

Talking about “Managing Toxicities Associated with #Sacituzumab Govitecan in mTNBC and HR+ MBC, with a Focus on Diarrhea and Neutropenia” w/ @VuMedi 👉🏼 https://t.co/zUs2vsYWOz

[Anna Amela Valsecchi @AAValsecchi]

Out our latest review 👉🏼 https://t.co/86qQlgKYCN

[Anna Amela Valsecchi @AAValsecchi]

#BREAST IMPROVEMENT NETWORK - Carcinoma mammario avanzato, dalla terapia target alla terapia #tailored 💖 Torino, 11/6/25 e 15/10/2025

[Massimo Di Maio @MassimoDiMaio75]

Standing ovation for this trial at #ASCO25 .
Practice changing.
The problem could be the adherence to physical exercise. Accrual in the trial was very slow, because many patients refused randomization to exercise, I suppose.
Education is crucial.

[Massimo Di Maio @MassimoDiMaio75]

Check out our open access review on the association between #QoL measures and survival endpoints in #cancer clinical trials and in clinical decision making.
Kudos to @AAValsecchi
https://t.co/WhWK015aPK

[Anna Amela Valsecchi @AAValsecchi]

🩵

[Meet-URO @meeturoIT]

Consegnati i Meet-URO Awards 2025:
Roberto Sabatini premiato per il contributo alla ricerca nei tumori genitourinari, Maria Concetta Cursano e Anna Amela Valsecchi vincono il Meet-URO YOUNG Award per il miglior progetto 2024.

@g_procopio_
@IstTumori
@UgoDeGiorgi
@oncodaily

[Anna Amela Valsecchi @AAValsecchi]

Delphy consensus on the management of #AEs in patients with #mTNBC treated with #sacituzumab govitecan 🎀 https://t.co/9WbznmGhQV

[Anna Amela Valsecchi @AAValsecchi]

Finally published our latest work: Press releases of industry-sponsored clinical trials in #oncology: Characteristics, timing and financial impact
📄 https://t.co/yJ2QTBHsPX @MassimoDiMaio75

[Anna Amela Valsecchi @AAValsecchi]

Look at our latest publication about #breastcancer studies 💕 https://t.co/NFF8EzQx9v
Thanks to @gaia_giannone and @Pasquale for involving me, and to all coauthors!

[Giuseppe Banna @gbanna74]

Grateful to the oncology residents at @unito for the warm welcome during their Didactic Week, fantastic initiative by Silvia Novello to learn, network & grow together.
Thanks to @LulieZumstein, @AAValsecchi & @O_Cantale for the flawless organization!
Loved their curiosity!